356 related articles for article (PubMed ID: 18589435)
1. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
[TBL] [Abstract][Full Text] [Related]
2. T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera.
Sogo T; Kawahara M; Ueda H; Otsu M; Onodera M; Nakauchi H; Nagamune T
Cytokine; 2009 Apr; 46(1):127-36. PubMed ID: 19223197
[TBL] [Abstract][Full Text] [Related]
3. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
[TBL] [Abstract][Full Text] [Related]
4. Selection and growth regulation of genetically modified cells with hapten-specific antibody/receptor tyrosine kinase chimera.
Tanaka K; Kawahara M; Ueda H; Nagamune T
Biotechnol Prog; 2009; 25(4):1138-45. PubMed ID: 19569211
[TBL] [Abstract][Full Text] [Related]
5. Early immune response and regulation of IL-2 receptor subunits.
Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
[TBL] [Abstract][Full Text] [Related]
6. Growth promotion of genetically modified hematopoietic progenitors using an antibody/c-Mpl chimera.
Kawahara M; Chen J; Sogo T; Teng J; Otsu M; Onodera M; Nakauchi H; Ueda H; Nagamune T
Cytokine; 2011 Sep; 55(3):402-8. PubMed ID: 21700475
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.
Nelson BH; Lord JD; Greenberg PD
Nature; 1994 May; 369(6478):333-6. PubMed ID: 7514277
[TBL] [Abstract][Full Text] [Related]
8. Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency.
Liu W; Kawahara M; Ueda H; Nagamune T
Biotechnol Bioeng; 2008 Dec; 101(5):975-84. PubMed ID: 18500765
[TBL] [Abstract][Full Text] [Related]
9. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.
Imbert V; Rezzonico R; Reichenbach P; Nabholz M
Eur Cytokine Netw; 2002; 13(3):331-9. PubMed ID: 12231477
[TBL] [Abstract][Full Text] [Related]
10. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
[TBL] [Abstract][Full Text] [Related]
11. Selection of genetically modified cell population using hapten-specific antibody/receptor chimera.
Kawahara M; Kimura H; Ueda H; Nagamune T
Biochem Biophys Res Commun; 2004 Feb; 315(1):132-8. PubMed ID: 15013436
[TBL] [Abstract][Full Text] [Related]
12. A synthetic peptide corresponding to a critical intracellular signaling region of the human IL-4 receptor inhibits IL-4-induced proliferation.
Izuhara K; Sakai M; Inaba R; Imamura T; Howard M; Harada N
Cell Immunol; 1995 Jul; 163(2):254-9. PubMed ID: 7606796
[TBL] [Abstract][Full Text] [Related]
13. IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork.
Pillet AH; Lavergne V; Pasquier V; Gesbert F; Thèze J; Rose T
J Mol Biol; 2010 Nov; 403(5):671-92. PubMed ID: 20816854
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
[TBL] [Abstract][Full Text] [Related]
15. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
16. IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2Rbeta transgenic mice.
Gesbert F; Moreau JL; Thèze J
Int Immunol; 2005 Aug; 17(8):1093-102. PubMed ID: 16037071
[TBL] [Abstract][Full Text] [Related]
17. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
[TBL] [Abstract][Full Text] [Related]
18. Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit.
Annenkov AE; Moyes SP; Eshhar Z; Mageed RA; Chernajovsky Y
J Immunol; 1998 Dec; 161(12):6604-13. PubMed ID: 9862688
[TBL] [Abstract][Full Text] [Related]
19. IL-2R alpha on one cell can present IL-2 to IL-2R beta/gamma(c) on another cell to augment IL-2 signaling.
Eicher DM; Waldmann TA
J Immunol; 1998 Nov; 161(10):5430-7. PubMed ID: 9820518
[TBL] [Abstract][Full Text] [Related]
20. Reversal of antigen-dependent signaling by two mutations in antibody/receptor chimera: implication of inverse agonism in cytokine receptor superfamily.
Kawahara M; Ishii S; Tsumoto K; Kumagai I; Ueda H; Nagamune T
Biochem Pharmacol; 2004 Aug; 68(3):539-48. PubMed ID: 15242820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
